Literature DB >> 21644508

β-arrestin-2 regulation of the cAMP response element binding protein.

Mary E Manson1, Deborah A Corey, Sharon M Rymut, Thomas J Kelley.   

Abstract

Previous work demonstrated that cystic fibrosis (CF) cells exhibit an increase in cAMP-mediated signaling as a characteristic response to lost CFTR function. Evidence for increased cAMP-mediated signaling in CF included increased phosphorylation of the cAMP response element binding protein (CREB) and elevated β-arrestin-2 (βarr2) expression. However, subsequent studies reveal that CREB activation in CF cells is independent of protein kinase-A (PKA). The goal of this study is to test the hypothesis that elevated βarr2 expression leads to increased CREB activation in a PKA-independent mechanism. βarr2-GFP expressing tracheal epithelial cells (βarr2-GFP) exhibit an increase of pCREB content and subsequent CRE activation compared to GFP expressing control cells. βarr2 activation of the ERK cascade represents a candidate mechanism leading to CREB activation. ERK exhibits increased activation in βarr2-GFP cells compared to cont-GFP cells, and ERK inhibition diminishes CRE activation in both GFP and βarr2-GFP cells. To test directly whether CREB regulation in CF is βarr2-dependent, nasal epithelium excised from wt mice (Cftr +/+; βarr2 +/+), CF mice (Cftr -/-; βarr2 +/+), and DKO mice (Cftr -/-; βarr2 -/-) were analyzed for pCREB protein content. Removal of βarr2 expression from CF mice reduces both pCREB and pERK content to wt levels. These data indicate that CF-related CREB regulation is mediated directly through βarr2 expression via the ERK pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21644508      PMCID: PMC3133940          DOI: 10.1021/bi200015h

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  39 in total

1.  In vivo alterations of IFN regulatory factor-1 and PIAS1 protein levels in cystic fibrosis epithelium.

Authors:  T J Kelley; H L Elmer
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex.

Authors:  K A DeFea; Z D Vaughn; E M O'Bryan; D Nishijima; O Déry; N W Bunnett
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

3.  Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency.

Authors:  Yan Xu; Jean C Clark; Bruce J Aronow; Chitta R Dey; Cong Liu; Jamie L Wooldridge; Jeffrey A Whitsett
Journal:  J Biol Chem       Date:  2002-12-12       Impact factor: 5.157

4.  Feedback inhibition of G protein-coupled receptor kinase 2 (GRK2) activity by extracellular signal-regulated kinases.

Authors:  J A Pitcher; J J Tesmer; J L Freeman; W D Capel; W C Stone; R J Lefkowitz
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

5.  Increased expression of G protein-coupled receptor kinases in cystic fibrosis lung.

Authors:  Judith C W Mak; Tsu Tshen Chuang; Carol A Harris; Peter J Barnes
Journal:  Eur J Pharmacol       Date:  2002-02-02       Impact factor: 4.432

6.  Mechanistic similarities between cultured cell models of cystic fibrosis and niemann-pick type C.

Authors:  Nicole M White; Deborah A Corey; Thomas J Kelley
Journal:  Am J Respir Cell Mol Biol       Date:  2004-07-15       Impact factor: 6.914

7.  Gene profile changes after Pseudomonas aeruginosa exposure in immortalized airway epithelial cells.

Authors:  Aura Perez; Pamela B Davis
Journal:  J Struct Funct Genomics       Date:  2004

8.  Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells.

Authors:  Norman E Kreiselmeier; Nathan C Kraynack; Deborah A Corey; Thomas J Kelley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-08-29       Impact factor: 5.464

9.  Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins.

Authors:  Stephen J Perry; George S Baillie; Trudy A Kohout; Ian McPhee; Maria M Magiera; Kok Long Ang; William E Miller; Alison J McLean; Marco Conti; Miles D Houslay; Robert J Lefkowitz
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

10.  Podophyllotoxin induces CREB phosphorylation and CRE-driven gene expression via PKA but not MAPKs.

Authors:  Ya Qiong Chen; Xin Xie
Journal:  Mol Cells       Date:  2009-12-18       Impact factor: 5.034

View more
  15 in total

1.  Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells.

Authors:  Sharon M Rymut; Binyu Lu; Aura Perez; Deborah A Corey; Kata Lamb; Calvin U Cotton; Thomas J Kelley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-20       Impact factor: 5.464

2.  β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.

Authors:  Anne O Watts; Folkert Verkaar; Miranda M C van der Lee; Claudia A W Timmerman; Martien Kuijer; Jody van Offenbeek; Lambertus H C J van Lith; Martine J Smit; Rob Leurs; Guido J R Zaman; Henry F Vischer
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

3.  Clinically-approved CFTR modulators rescue Nrf2 dysfunction in cystic fibrosis airway epithelia.

Authors:  Dana C Borcherding; Matthew E Siefert; Songbai Lin; John Brewington; Hesham Sadek; John P Clancy; Scott M Plafker; Assem G Ziady
Journal:  J Clin Invest       Date:  2019-05-30       Impact factor: 14.808

Review 4.  Molecular pathways for intracellular cholesterol accumulation: common pathogenic mechanisms in Niemann-Pick disease Type C and cystic fibrosis.

Authors:  Nicholas L Cianciola; Cathleen R Carlin; Thomas J Kelley
Journal:  Arch Biochem Biophys       Date:  2011-09-05       Impact factor: 4.013

5.  Regulatory role of β-arrestin-2 in cholesterol processing in cystic fibrosis epithelial cells.

Authors:  Mary E Manson; Deborah A Corey; Ilya Bederman; James D Burgess; Thomas J Kelley
Journal:  J Lipid Res       Date:  2012-04-22       Impact factor: 5.922

Review 6.  The emerging roles of β-arrestins in fibrotic diseases.

Authors:  Yuan-jing Gu; Wu-yi Sun; Sen Zhang; Jing-jing Wu; Wei Wei
Journal:  Acta Pharmacol Sin       Date:  2015-09-21       Impact factor: 6.150

7.  Reduced caveolin-1 promotes hyperinflammation due to abnormal heme oxygenase-1 localization in lipopolysaccharide-challenged macrophages with dysfunctional cystic fibrosis transmembrane conductance regulator.

Authors:  Ping-Xia Zhang; Thomas S Murray; Valeria R Villella; Eleonora Ferrari; Speranza Esposito; Anthony D'Souza; Valeria Raia; Luigi Maiuri; Diane S Krause; Marie E Egan; Emanuela M Bruscia
Journal:  J Immunol       Date:  2013-04-19       Impact factor: 5.422

8.  Resveratrol restores intracellular transport in cystic fibrosis epithelial cells.

Authors:  Binyu Lu; Deborah A Corey; Thomas J Kelley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-04-08       Impact factor: 5.464

Review 9.  β-Arrestins in the immune system.

Authors:  Dianhua Jiang; Ting Xie; Jiurong Liang; Paul W Noble
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

10.  PAF enhances MMP-2 production in rat aortic VSMCs via a β-arrestin2-dependent ERK signaling pathway.

Authors:  Yun H Kim; Seung J Lee; Kyo W Seo; Jin U Bae; So Y Park; Eun K Kim; Sun S Bae; Jae H Kim; Chi D Kim
Journal:  J Lipid Res       Date:  2013-08-02       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.